NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE272346 Query DataSets for GSE272346
Status Public on Sep 13, 2024
Title Late-stage tertiary lymphoid structures in hepatocellular carcinoma treated with neoadjuvant immune checkpoint blockade [bulk RNA-seq]
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Tertiary lymphoid structures (TLS) are associated with improved response in solid tumors treated with immune checkpoint blockade (ICB), but understanding of their clinical significance and the circumstances of their resolution remains incomplete. Here, we found that in hepatocellular carcinoma (HCC) treated with neoadjuvant immunotherapy, high intratumoral TLS density at the time of surgery is associated with pathologic response and improved relapse free survival. In areas of tumor regression, we further identified a non-canonical involuted morphology of TLS marked by dispersion of the B cell follicle, persistence of a T cell zone enriched for T cell-mature dendritic cell interactions, and increased expression of T cell memory markers. Collectively, these data suggest that TLS may serve be both a prognostic and predictive marker of response to immunotherapy in HCC and suggest a functional role for late-stage TLS T cell memory formation after elimination of viable tumor.
 
Overall design We utilized surgical resection specimens and peripheral blood obtained from patients with locally advanced hepatocellular carcinoma receiving neoadjuvant immune checkpoint blockade based therapy. Bulk RNA sequencing was performed on post-treatment tumor resection specimens to characterize differences in gene expression between tumors with high and low density of tertiary lymphoid structures. Tumor associated tertiary lymphoid structures were microdissected and subjected to bulk TCR and BCR sequencing using the Adaptive Biotechnologies ImmunoSEQ platform (shared separately). Single cell RNA, TCR, and BCR sequencing was performed on matched peripheral blood and tumor specimens to infer the identity of T and B cells identified in tertiary lymphoid structures.

*** Submitters state that raw data is being submitted to dbGap (phs003672.v1.p1)***
 
Contributor(s) Shu D, Yarchoan M
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jul 16, 2024
Last update date Sep 14, 2024
Contact name Daniel H Shu
E-mail(s) daniel.shu@jhmi.edu
Organization name Johns Hopkins Sidney Kimmel Cancer Center
Department Oncology
Street address CRB1, RM 416, 1550 ORLEANS ST.
City BALTIMORE
State/province Maryland
ZIP/Postal code 21287
Country USA
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (14)
GSM8398966 P01, tumor, bulkRNAseq and reconstructed TCR/BCR repertoires
GSM8398967 P02, tumor, bulkRNAseq and reconstructed TCR/BCR repertoires
GSM8398968 P03, tumor, bulkRNAseq and reconstructed TCR/BCR repertoires
This SubSeries is part of SuperSeries:
GSE272348 Late-stage tertiary lymphoid structures in hepatocellular carcinoma treated with neoadjuvant immune checkpoint blockade
Relations
BioProject PRJNA1136492

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE272346_RAW.tar 7.5 Mb (http)(custom) TAR (of TSV)
Raw data not provided for this record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap